Reply: A single cut-off value of anti-Mullerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women

Affiliations

Comment

Robin J Bell et al. Hum Reprod. 2022.

. 2022 Mar 1;37(3):622.

doi: 10.1093/humrep/deac013.

¹ Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.

No abstract available

Comment on

Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR. Bell RJ, et al. Hum Reprod. 2021 Dec 27;37(1):109-118. doi: 10.1093/humrep/deab232. Hum Reprod. 2021. PMID: 34741176
A single cut-off value of anti-Müllerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women.
Mahboobifard F, Rahmati M, Ramezani Tehrani F. Mahboobifard F, et al. Hum Reprod. 2022 Mar 1;37(3):621-622. doi: 10.1093/humrep/deac012. Hum Reprod. 2022. PMID: 35106559 No abstract available.